arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Cadre Holdings, Inc.

CDRE
$26.23 ▼ -0.51 (-1.91%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
27 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

Cadre Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.1B
Dividend Yield 0.38%
Revenue Growth 31.8% ↗
Op. Margin 10.8% ↗
ROIC 2.2% ↗
FCF / Share $0.44 ↘
Trailing P/E 97.2x
Price / Book 3.2x
FCF Yield 1.7%
Debt / Equity 1.02
info Valuation on last close. End-of-day price, Sep 24, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$207.13M
↑ +31.8% —
Net Income Profit after all expenses
$1.98M
↓ -78.6% —
Operating Margin Operating profit as % of sales
10.8%
↑ +125.0% 59th
FCF / Share Free cash flow per share
$0.44
↓ -6.4% —
Long-Term Debt Long-term obligations
$354.32M
↑ +1.4% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
58
Returns →
78
Financial Health →
50
Cash Quality ↓
75

Dividend History

Dividend / share · sourced from SEC filings
$0.10 Latest / share
+8.6% YoY
+5.9% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 7 years · 27 quarters